Influenza Virus Surveillance from the 1918 Influenza Pandemic to the 2020 Coronavirus Pandemic in New York State, USA
Kay L Escuyer1, Donna L Gowie2, Kirsten St George1
1Wadsworth Center, David Axelrod Institute, New York State Department of Health, Albany, NY 12208, USA.
Related Experiment Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
05:21A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
08:52Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
Published on: July 26, 2019
View abstract on PubMed
New York State public health laboratory influenza surveillance met recommended goals when data from clinical labs were included. Continued specimen submissions are vital for detecting emerging viruses and pandemic preparedness.
Area of Science:
- Public Health
- Virology
- Epidemiology
Background:
- Influenza surveillance in New York State has evolved over 100 years, integrating advanced technologies like next-generation sequencing.
- Effective surveillance is crucial for pandemic preparedness and response, requiring sufficient specimen testing within confidence limits.
Purpose of the Study:
- To evaluate if influenza virologic surveillance at the New York State Public Health Laboratory (NYS PHL) collects adequate specimen numbers for situational awareness and novel pandemic virus detection.
- To assess surveillance data against guidelines from the Association of Public Health Laboratories and Centers for Disease Control and Prevention's Influenza Virologic Surveillance Right Size Roadmap.
Main Methods:
- Retrospective analysis of electronic laboratory test results for influenza seasons from 1997-1998 to 2021-2022.
- Comparison of specimen numbers tested at NYS PHL against recommended sample sizes for effective surveillance.
Main Results:
- Influenza virologic surveillance data solely from NYS PHL specimens were insufficient to meet recommended surveillance goals.
- When supplemented with testing data from participating clinical laboratories, the surveillance program achieved the recommended goals.
- Influenza remains a significant public health threat, as evidenced by case increases surrounding the COVID-19 pandemic.
Conclusions:
- Collaboration between public health and clinical laboratories is essential for robust influenza surveillance.
- Sustained and encouraged sample submissions to public health laboratories are critical for monitoring emerging influenza viruses and ensuring pandemic preparedness.
Related Concept Videos
Viral Mutations
Viral Recombination